Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study-Reference-Cited by-同舟云学术

Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study

Published:2019-07-01 Issue:13 Volume:58 Page:1835-1844
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hatanaka Takeshi¹,Kakizaki Satoru²,Uehara Daisuke²,Nagashima Tamon³,Ueno Takashi⁴,Namikawa Masashi⁵,Saito Shuichi⁶,Hosonuma Kenichi⁷,Suzuki Hideyuki⁸,Naganuma Atsushi⁹,Takagi Hitoshi¹⁰,Sato Ken²,Uraoka Toshio²

Affiliation:

1. Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Japan

2. Department of Gastroenterology and Hepatology, Gunma University Graduate School of Medicine, Japan

3. Department of Gastroenterology, Shibukawa Medical Center, National Hospital Organization, Japan

4. Department of Internal Medicine, Isesaki Municipal Hospital, Japan

5. Department of Internal Medicine, Kiryu Kosei General Hospital, Japan

6. Department of Gastroenterology, Tomioka General Hospital, Japan

7. Department of Internal Medicine, Toho Hospital, Japan

8. Department of Internal Medicine, Haramachi Red Cross Hospital, Japan

9. Department of Gastroenterology, Takasaki General Medical Center, National Hospital Organization, Japan

10. Department of Gastroenterology and Hepatology, Kusunoki Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/13/58_1594-18/_pdf

Reference39 articles.

1. 1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359-E386, 2015.

2. 2. McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 19: 223-238, 2015.

3. 3. Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150: 835-853, 2016.

4. 4. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022, 2011.

5. 5. Kudo M, Matsui O, Izumi N, et al. JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the Liver Cancer Study Group of Japan. Liver Cancer 3: 458-468, 2014.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutritional assessment and following nutritional intervention during drug therapy for patients with hepatobiliary carcinoma;The Japanese Journal of SURGICAL METABOLISM and NUTRITION;2023-12-15

2. Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors;Human Vaccines & Immunotherapeutics;2023-08

3. Advanced Hepatocellular Cancer Treated with Sorafenib and Novel Inflammatory Markers;Journal of Gastrointestinal Cancer;2022-02-04

4. Impact of prognostic nutritional index on the recurrence of hepatocellular carcinoma after a curative resection;Annals of Hepato-Biliary-Pancreatic Surgery;2021-11-30

5. Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib;Hepatology Research;2021-05-26